0001209191-17-053232.txt : 20170918 0001209191-17-053232.hdr.sgml : 20170918 20170918210603 ACCESSION NUMBER: 0001209191-17-053232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170914 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 171090998 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-14 0 0001625101 Pulse Biosciences, Inc. PLSE 0001055919 DUGGAN ROBERT W 611 S. FORT HARRISON AVE., SUITE 306 CLEARWATER FL 33756 0 0 1 0 Common Stock 2017-09-14 4 P 0 50300 11.6622 A 3437994 D Common Stock 2017-09-14 4 P 0 30050 12.774 A 3468044 D Common Stock 2017-09-14 4 P 0 53820 13.9007 A 3521864 D Common Stock 2017-09-14 4 P 0 47450 14.5697 A 3569314 D Common Stock 2017-09-15 4 P 0 71598 14.3791 A 3640912 D Common Stock 2017-09-15 4 P 0 125000 15.7047 A 3765912 D Common Stock 2017-09-15 4 P 0 500 16.215 A 3766412 D Common Stock 2017-09-18 4 P 0 23703 15.1155 A 3790115 D Common Stock 2017-09-18 4 P 0 7497 15.4962 A 3797612 D Common Stock 35000 I See footnote This is the weighted average purchase price of the shares, which ranged from $11.1366 to $12.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $12.14 to $13.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $13.255 to $14.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $14.265 to $15.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $14.16 to $15.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $15.18 to $16.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $16.195 to $16.22 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $14.4015 to $15.3999 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $15.4463 to $15.569 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder. Brian Dow, as Attorney-in-Fact for Robert W. Duggan 2017-09-18